MedPath

Adlarity

These highlights do not include all the information needed to use ADLARITY safely and effectively. See full prescribing information for ADLARITY. ADLARITY® (donepezil transdermal system) Initial U.S. Approval : 1996

Approved
Approval ID

1cb44c65-00e8-4b5c-99c2-ad15173115a0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 17, 2023

Manufacturers
FDA

Corium, LLC.

DUNS: 839674207

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Donepezil Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65038-055
Application NumberNDA212304
Product Classification
M
Marketing Category
C73594
G
Generic Name
Donepezil Hydrochloride
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateFebruary 17, 2023
FDA Product Classification

INGREDIENTS (8)

Donepezil hydrochlorideActive
Quantity: 5 mg in 1 1
Code: 3O2T2PJ89D
Classification: ACTIB
GlycerinInactive
Code: PDC6A3C0OX
Classification: IACT
Triethyl CitrateInactive
Code: 8Z96QXD6UM
Classification: IACT
Sorbitan MonolaurateInactive
Code: 6W9PS8B71J
Classification: IACT
CrospovidoneInactive
Code: 2S7830E561
Classification: IACT
Lauryl LactateInactive
Code: G5SU0BFK7O
Classification: IACT
Sodium BicarbonateInactive
Code: 8MDF5V39QO
Classification: IACT
Ascorbyl PalmitateInactive
Code: QN83US2B0N
Classification: IACT

Donepezil Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65038-056
Application NumberNDA212304
Product Classification
M
Marketing Category
C73594
G
Generic Name
Donepezil Hydrochloride
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateFebruary 17, 2023
FDA Product Classification

INGREDIENTS (8)

Donepezil hydrochlorideActive
Quantity: 10 mg in 1 1
Code: 3O2T2PJ89D
Classification: ACTIB
GlycerinInactive
Code: PDC6A3C0OX
Classification: IACT
Triethyl CitrateInactive
Code: 8Z96QXD6UM
Classification: IACT
Sorbitan MonolaurateInactive
Code: 6W9PS8B71J
Classification: IACT
Sodium BicarbonateInactive
Code: 8MDF5V39QO
Classification: IACT
CrospovidoneInactive
Code: 2S7830E561
Classification: IACT
Lauryl LactateInactive
Code: G5SU0BFK7O
Classification: IACT
Ascorbyl PalmitateInactive
Code: QN83US2B0N
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Adlarity - FDA Drug Approval Details